Tradestie Institutional Equity Comparison Engine
EQ vs ECOR โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
EQ Overall Edge
EQ Captures Institutional Edge (4โ0 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Equillium, Inc. Common Stock (EQ) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, EQ trades at 1.5x Forward P/E with 0.0% operating margin (-52.3% YoY revenue) versus ECOR at N/M Forward P/E and -33.1% operating margin (+11.5% YoY). In options structure, EQ sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro) against ECOR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
EQ
EQ 1.5x vs ECOR N/M Fwd P/E
Growth & Margin Winner
EQ
Op Margin 0.0% vs -33.1% ยท YoY -52.3% vs +11.5%
Momentum & Technical Winner
EQ
1Y +12.0% vs -4.0% ยท 52W Pos 11% vs 6%
Options & Structure Winner
EQ
UNCLASSIFIED (100th %ile IV) vs UNCLASSIFIED (N/A IV)
EQ
NASDAQ
Equillium, Inc. Common Stock
Pharmaceutical Preparations
$1.12
+1.82% 1D
Market Cap
$90.6M
1M Return
-21.13%
1Y Return
+12.0%
Forward P/E
1.5x
Unified AI Score
48.0 / 100
HOLD
Tech 30.0
Fund 51.0
Flow 63.0
Mom 60.0
ECOR
NASDAQ
electroCore, Inc. Common Stock
Electromedical & Electrotherapeutic Apparatus
$4.85
-6.19% 1D
Market Cap
$47.7M
1M Return
-34.01%
1Y Return
-3.96%
Forward P/E
N/M
Unified AI Score
56.8 / 100
HOLD
Tech 68.0
Fund 53.0
Flow 50.0
Mom 64.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
EQ +12.0%
ECOR -3.96%
Spread: +15.96 pp (EQ Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | EQ Revenue | ECOR Revenue | EQ Op. Margin | ECOR Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | N/A | $0M | N/A | -5494.1% | ECOR |
| FY2019 | N/A | $0M | N/A | -1928.2% | ECOR |
| FY2020 | N/A | $0M | N/A | -707.9% | ECOR |
| FY2021 | N/A | $10M | N/A | -367.7% | ECOR |
| FY2022 | $20M | $10M | -393.9% | -266.2% | ECOR |
| FY2023 | $40M | $20M | -40.2% | -120.2% | EQ |
| FY2024 | $40M | $30M | -20.1% | -48.3% | EQ |
| FY2025 | N/A | $30M | N/A | -41.1% | ECOR |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | EQ | ECOR | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $90.6M | $47.7M | Larger Scale | EQ |
| Trailing P/E Ratio Valuation | 1.5x | N/M | Lower Multiple | EQ |
| Forward P/E Ratio Valuation | 1.5x | N/M | Lower Multiple | EQ |
| Revenue Growth (YoY) Growth | -52.3% | +11.5% | Higher Growth | ECOR |
| Operating Margin (TTM) Profitability | 0.0% | -33.1% | Higher Margin | EQ |
| Net Profit Margin Profitability | 0.0% | -33.5% | Higher Margin | EQ |
| Return on Equity (ROE) Capital Efficiency | -59.0% | -478.7% | Higher ROE | EQ |
| 52-Week Range Position Momentum | 11% ($1โ$4) | 6% ($4โ$13) | Stronger Trend | EQ |
| Beta / 30D Volatility Risk Regime | 1.53ฮฒ ยท 93% Vol | 1.52ฮฒ ยท 155% Vol | Lower Realized Risk | EQ |
| Unified Institutional Score Composite Signal | 48.0 / 100 (HOLD) | 56.8 / 100 (HOLD) | Higher Composite | ECOR |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full EQ vs ECOR Buy Guide
EQ
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
100th %ile
IV Regime
Extreme (>80th %ile)
ECOR
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither EQ nor ECOR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.